Manje i-XBB 1.5 Variant iyahlukahluka phakathi komhlaba. Elinye iklayenti lingabaza uma ukuhlolwa kwethu okusheshayo kwe-Antigen-19 kungakuthola lokhu okuhlukile noma cha.

I-Spike Glycoprotein ikhona ebusweni be-coronavirus yenoveli futhi iguqulwe kalula njenge-Alpha Variant (B.1.1.651), i-Omicron variant (B.1.617), i-Omicron variant (B.1.617), i-Omicron variant (B.1.617), i-Omicron variant (i-XBB1.5) nokunye.
I-viral nucleocapsopsid yakhiwa amaprotheni we-nucleocapsid (n amaprotheni amafushane) ne-RNA. I-protein n iqinile, ingxenye enkulu kunazo zonke kumaprotheni ahlelekile ahlelekile kanye nokuzwela okuphezulu ekutholweni.
Ngokusekelwe kwizici ze-protein n, i-monoclonal antibody of n protein ngenoveli
ICoronavirus yakhethwa ekuthuthukiseni nasekuklameni komkhiqizo wethu ogama lakhe "Sars-Cov-2 Antigen Rapid Test (Colloidal Gold)" okuhloselwe ukutholwa kwe-SARS-cov-2 ku-nasal swab specimentens in vitro ngokusebenzisa amaprotheni atholayo.
Lokho kusho ukuthi, i-spike glycoprotein mutant strain kufaka phakathi i-XBB1.5 ayithinti umphumela wokuhlola.
Ngakho-ke, thinaAbakwa-SARS-Cov-2 Antigenangabona i-XBB 1.5